Key Takeaways from Analyst
The global chemotherapy market continues to grow in size owing to the rising incidence of cancer cases worldwide. The growing geriatric population who are more prone to develop cancer also drives demand. However, the market faces restraints from the toxic side effects of chemotherapy drugs that can reduce patient compliance.
Additionally, the development of targeted therapies that have fewer side effects poses a threat to chemotherapy drug sales over the long run.
North America currently dominates the chemotherapy market and is expected to continue its leadership. This is attributed to factors such as the early adoption of novel drugs and the presence of prominent manufacturers in the region. Meanwhile, Asia Pacific is projected to witness the highest growth and emerge as the fastest-growing regional market. This can be accredited to rising healthcare investments, growing public awareness, and increasing penetration of healthcare insurance in developing Asian countries.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients